Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias-Reference-Cited by-同舟云学术

Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias

Published:2016-10-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Foong Wai Cheng¹,Ho Jacqueline J¹,Loh C Khai²,Viprakasit Vip³

Affiliation:

1. Penang Medical College; Department of Paediatrics; No 4 Sepoy Lines Penang Malaysia 10450

2. Universiti Kebangsaan Malaysia Medical Centre; Department of Paediatrics; Jalan Yaacob Latif, Bandar Tub Razak 56000 Cheras Kuala Lumpur Malaysia

3. Faculty of Medicine Siriraj Hospital, Mahidol University; Haematology/Oncology Division, Department of Paediatrics; 2 Prannok Road, Bangkoknoi Bangkok Thailand 10700

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011579.pub2/epdf/full

Reference76 articles.

1. Optimizing the dose of hydroxyurea in thalassemia intermedia (Conference abstract);Bohara;Indian Journal Hematology Blood Transfusion,2012

2. Optimizing the dose of hydroxyurea therapy for patients with beta-thalassemia intermedia (Hb E-beta-thalassemia): a single center study from Eastern India;Bohara;Hemoglobin,2014

3. The role of hydroxyurea and valproic acid in the management of severe HbE-ß thalassaemia (Conference abstract);Biswas;Indian Journal of Hematology & Blood Transfusion,2014

4. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young beta-thalassemia intermedia patients;Elalfy;European Journal of Haematology,2013

5. Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia;Karimi;European Journal of Haematology,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous adjunctive treatment of malaria and its coevolved genetic disorder sickle cell anemia;Blood Advances;2023-10-10

2. Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias;Cochrane Database of Systematic Reviews;2023-01-13

3. A comprehensive study of immune function and immunophenotyping of white blood cells from β‐thalassaemia/ HbE patients on hydroxyurea supports the safety of the drug;British Journal of Haematology;2022-10-11

4. Simultaneous adjunctive treatment of malaria and its co-evolved genetic disorder sickle cell anaemia;2022-09-02

5. A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs;Wellcome Open Research;2022-08-17